0000014272-16-000442.txt : 20160705 0000014272-16-000442.hdr.sgml : 20160705 20160705185655 ACCESSION NUMBER: 0000014272-16-000442 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160630 FILED AS OF DATE: 20160705 DATE AS OF CHANGE: 20160705 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BRISTOL MYERS SQUIBB CO CENTRAL INDEX KEY: 0000014272 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 220790350 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 BUSINESS PHONE: 2125464000 MAIL ADDRESS: STREET 1: 345 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10154 FORMER COMPANY: FORMER CONFORMED NAME: BRISTOL MYERS CO DATE OF NAME CHANGE: 19891012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynch Thomas J. Jr. CENTRAL INDEX KEY: 0001474056 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-01136 FILM NUMBER: 161752060 MAIL ADDRESS: STREET 1: 800 HOWARD AVENUE STREET 2: YALE PHYSICIANS BUILDING, 2ND FLOOR CITY: NEW HAVEN STATE: CT ZIP: 06519 4 1 wf-form4_146775940264531.xml FORM 4 X0306 4 2016-06-30 0 0000014272 BRISTOL MYERS SQUIBB CO BMY 0001474056 Lynch Thomas J. Jr. BRISTOL-MYERS SQUIBB COMPANY 345 PARK AVENUE NEW YORK NY 10154 1 0 0 0 Deferred Share Units 2016-06-30 4 A 0 104.096 73.55 A Common Stock, $0.10 par value 104.096 10397.385 D Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person. Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors. /s/ Katherine Kelly, attorney-in-fact for Thomas J. Lynch, Jr. M.D. 2016-07-05